U.S. Industrials Stock News

Campbell's stock has retreated sharply over the past few years, yet some of the current valuation checks still view the shares as not outright expensive or cheap. Recent cost cuts, a reduced dividend and weaker profitability now sit against a mixed read on value rather than a clear bargain. The share price has fallen 44.2% over the past three years, which signals that investors have been marking down expectations for the business. A planned US$500m cost reduction program can support margins...

Kaspi.kz (KSPI) has approved a KZT 1,000 dividend per common share for the second quarter of 2026 at its Extraordinary General Meeting, with payments scheduled to begin on 9 September 2026. Kaspi.kz shares closed at $99.96 on 10 September, with a 1 day share price return of 2.89% after the dividend news, while the 90 day share price return of 24.08% and 1 year total shareholder return of 26.30% indicate that momentum has been building rather than fading. Scan other dividend heavyweights with...

Gorman-Rupp reported record second quarter net sales and earnings per share, supported by solid demand from construction, agriculture, and data center projects, alongside strong operating cash flow that allowed further debt reduction and continued reinvestment in the business. Healthy incoming orders and backlog painted a firm operational picture, yet investor reaction stayed cautious, suggesting concerns about how these record results align with earlier expectations and future demand...

Axsome Therapeutics recently reported that the first patient has been dosed in SUMMIT, a Phase 3 trial evaluating AXS-05 for smoking cessation against bupropion and placebo over 12 weeks. The primary endpoint is abstinence at week 12. The SUMMIT study evaluates whether Axsome Therapeutics can extend AXS-05 beyond its current approvals. This would broaden the product’s potential use while leveraging a patent estate that runs at least to 2043. This article examines how Axsome Therapeutics'...

Realty Income presents an unusual valuation split right now, with its Discounted Cash Flow (DCF) intrinsic value estimate pointing to a large gap to the upside, while traditional market multiples suggest the stock is not cheap and the broader value score reads as weak. Over the past 3 years, Realty Income has returned about 29.9%, which suggests the long term income story has still been rewarded even through recent share price softness. The 5.3% dividend yield and long record of monthly...

Astera Labs has climbed 62.2% year to date, yet valuation checks point to a stock that appears expensive on most measures and only roughly aligned with its intrinsic value estimate rather than clearly cheap. The 62.2% year to date gain sets a high bar for future returns and leaves little room for disappointment in the story investors are paying for. Expectations for ongoing growth in high speed connectivity solutions can support the current share price, while any slowdown in cash flow...

BioMarin Pharmaceutical (NasdaqGS:BMRN) reported positive Phase 3 VOXZOGO results in children with hypochondroplasia, published in NEJM Evidence. The company filed a supplemental application with the FDA to expand VOXZOGO’s label as a targeted therapy for hypochondroplasia. VOXZOGO is positioned as a potential first approved treatment for hypochondroplasia, building on its existing indication in achondroplasia. The new VOXZOGO hypochondroplasia data and FDA filing come alongside broader...

The market finally blinked. Macy’s stock jumped 7.7% to US$22.08 after earnings, even though the past 90 days left holders down about 13%. Traders rushed back in because the headline was simple enough to cut through the noise. Comparable sales rose 2.7% and adjusted earnings per share landed at roughly US$0.64. That move is really a verdict on one thing. The retailer showed that its “Bold New Chapter” playbook can produce higher comps and a 41.5% gross margin in a tough department store...

OUTFRONT Media (OUT) is set to present at Citi’s 2026 Global TMT Conference in New York on September 8, 2026, with Chief Executive Officer Nick Brien scheduled to speak. Recent trading has been choppy for OUTFRONT Media, with the share price slipping 4.7% over the past month and 8.7% over the last quarter, even after a 20.7% year to date share price return and a 58.2% total shareholder return over the past year. This points to longer term momentum holding up while shorter term sentiment cools...

IDEX stock has delivered a 41.7% gain over the past year, yet the valuation picture is split, with an intrinsic value estimate pointing to upside while traditional market multiples lean the other way. For investors, that contrast raises questions about how much of IDEX's cash flow potential is already reflected in the current share price around US$224. The 41.7% 1 year return signals strong recent enthusiasm for IDEX, which can limit the margin of error if expectations prove too...

UiPath (NYSE:PATH) released a global report highlighting orchestration as a key factor in scaling agentic AI beyond pilots. The research draws on enterprise survey data that points to connecting data, systems, and employees as a main adoption challenge. Philippines based PLDT Inc. used UiPath orchestration to roll out agentic AI at scale, reporting large productivity gains and faster customer response. UiPath's new orchestration report and the PLDT deployment are only part of the broader...

Board refresh puts governance in focus for AT&T AT&T (T) just expanded its board from 10 to 11 directors, bringing in Fazal F. Merchant, a veteran finance executive with extensive transaction and technology experience. Merchant joins both the Audit and the Corporate Development and Finance Committees. This places him close to oversight of AT&T’s balance sheet, capital allocation and potential deal activity at a time when investors are watching those areas closely. AT&T shares have picked up...

PTC (PTC) has drawn investor attention after recent trading left the stock down about 12% over the past month, even as the past 3 months show a gain of roughly 15%. Viewed over a longer stretch, PTC’s recent slide fits into a tougher year, with the year to date share price return down 23.12% and the 1 year total shareholder return declining 36.24%, even though the 90 day share price return is up 15.04%. Scan how PTC compares to other software names under pressure this year by reviewing our...

Talen Energy has delivered a very large gain over the past three years, yet the share price has recently pulled back and the valuation checks now point to a mixed picture rather than a clear bargain or clear overpricing. Over the past three years, Talen Energy is up very sharply, which puts the current weakness into the context of a powerful earlier recovery. Future valuation can depend on how reliably the business converts its asset base into cash flow. Any setback in execution or higher...

Lam Research (LRCX) is back in focus after Barometer Capital Management flagged the stock as a key positive contributor in Q2 2026, citing strong exposure to memory equipment tied to AI demand. Lam Research shares have cooled in recent weeks, with the 30-day share price return down 8.6% and the 90-day move down 18.7%. The stock still carries a strong year to date share price gain of 61.2% and a one year total shareholder return of 156.4%. Momentum has therefore eased near the US$298.22 level...

Caterpillar (NYSE:CAT) introduced the Cat D11 XE electric-drive dozer, highlighting gains in fuel efficiency, productivity, and emissions performance. The firm reported record power and energy sales, tied to strong data center demand and changing preferences in generator technology. Management linked results to a shift toward hybrid and battery-integrated generator systems in the global power market. The Cat D11 XE launch and record power and energy performance sit within wider shifts our...

Kulicke and Soffa Industries (KLIC) just put its Thermo Compression Bonding and fluxless packaging technology in the spotlight as the semiconductor sector leans into Co Packaged Optics for AI focused networking and data center hardware. Recent trading has reflected that story. Kulicke and Soffa Industries has seen the share price climb 3.75% over the last day and 5.48% across the week, yet pull back 9.53% over 30 days and 23.91% over 90 days. A 78.05% year to date share price return and...

InterDigital’s latest damages claim against Walt Disney (DIS), seeking €101.7 million over streaming video patents after several European injunctions, has pushed legal risk around Disney’s direct to consumer platforms back into focus. Disney’s legal setback lands at a tricky moment for the stock, with the 90 day share price return of 6.5% and 30 day gain of 3.2% contrasting with a year to date share price decline of 4.7%. Legal headlines, new content like National Geographic’s upcoming AFRICA...

Willis Towers Watson (WTW) has put AI execution in sharper focus after announcing a partnership with Lyzr, aiming to help clients embed agentic AI workflows directly into everyday operations and workforce decisions. Recent trading shows a mixed picture for Willis Towers Watson. The share price is US$315.61 after a 7 day decline of 5.71% and a 30 day fall of 7.25%. However, the 90 day share price return of 20.17% and 3 year total shareholder return of 59.87% point to momentum that has built...

Laureate Education (LAUR) most recently closed at $36.14, drawing fresh attention from investors reviewing education stocks after a period of mixed short term returns and a stronger performance over the past year. The recent 1-day share price gain of 1.02% comes after softer 7-day and 30-day share price returns. Laureate Education’s 1-year total shareholder return of 22.97% and very large 5-year total shareholder return of about 3.4x suggest longer term momentum has been much stronger than...

STAAR Surgical (NasdaqGM:STAA) released a global market report on 12 September 2026 on vision correction procedure trends. The study highlights a structural shift in multiple regions away from laser eye surgery toward implantable lens correction using phakic ICLs. STAAR Surgical reports that surgeons and patients show growing interest in reversible procedures that are presented as carrying safety advantages. This fresh data on a move from laser to implantable lens correction should not be...

IBEX just jumped 6.8% to about $39.80, which indicates that traders reacted positively to the headline. The company reported record full year revenue of $644.1m and adjusted earnings per share of $3.52, while holding a net cash position of roughly $30.9m. In the short term, this reflects a relief pop after a stronger than usual quarter. For anyone with a longer time horizon measured in years rather than days, the combination of rising revenue and improving profitability is an important part...

QUALCOMM (QCOM) under CEO Cristiano Amon is intensifying investment in 6G research, AI data centers, robotics, and edge computing. The company is highlighting new use cases for 6G such as integrated sensing along with AI applications in smart infrastructure and national security. Management is framing this shift as a move beyond mobile devices toward broader wireless and AI-enabled markets. QUALCOMM's 6G and AI expansion push under Cristiano Amon comes alongside wider shifts our research has...

Central banks are hinting at interest rate shifts while trade policy keeps markets on edge, and that mix can quickly reward or punish global cyclical growth stocks exposed to these crosswinds. Miss the right stories and you risk watching others catch the upside in real time. This article explains how this backdrop connects to three specific stocks from our Global Cyclical Growth Stocks screener and why their reactions to the news deserve a closer look. The three stocks highlighted below are...